M.KirbyM
First clinical trial to investigate the efficacy and safety of combined SGLT2 inhibitor and GLP-1R agonist therapy in patients with T2DM, suggesting additive or synergistic effects on weight loss
Blood Sugar and Metabolic Support GLP-1 medications are also used for insulin regulation and blood sugar control , which can be especially helpful for individuals with metabolic concerns
Gallbladder risk is a known tradeoff of GLP-1 therapy, and managing it well means working with a provider before and during treatment, not waiting until symptoms escalate
Many active people do better with some carbohydrate intake, especially if they are lifting weights, walking regularly, or doing other structured exercise
Your provider monitors your progress, manages side effects, adjusts your dose during the escalation phase, orders periodic lab work, and ensures the medication continues to be safe and effective